SEC 13F Intelligence

Pggm Investments / BSX

Pggm Investments’s Boston Scientific Corp Position

Does Pggm Investments own Boston Scientific Corp (BSX)? Not currently — the last reported position was 147.2K shares worth $16M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$16M
Q2 2025
Shares
147.2K
% of Portfolio
+0.27%
Quarters Held
12
position exited

Position History BSX

Reported value by quarter
Q2 ’21: $182,000Q2 ’21Q4 ’22: $2MQ1 ’23: $5MQ1 ’23Q2 ’23: $12MQ3 ’23: $7MQ3 ’23Q4 ’23: $6MQ1 ’24: $7MQ1 ’24Q2 ’24: $9MQ3 ’24: $11MQ3 ’24Q4 ’24: $17MQ1 ’25: $19MQ1 ’25Q2 ’25: $16Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025147.2K$16M+0.27%
Q1 2025192.0K$19M+0.26%
Q4 2024192.0K$17M+0.23%
Q3 2024130.6K$11M+0.14%
Q2 2024117.8K$9M+0.13%
Q1 2024107.4K$7M+0.11%
Q4 2023110.6K$6M+0.10%
Q3 2023138.9K$7M+0.13%
Q2 2023215.8K$12M+0.19%
Q1 202391.4K$5M+0.08%
Q4 202239.2K$2M+0.03%
Q2 20214.3K$182,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pggm Investments’s full portfolio or all institutional holders of BSX.